Cyclopamine analogues and methods of use thereof
The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.
1. A process comprising:
a. reacting a first compound of formula 2:
wherein each R 1 and R 8 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, alkoxyl, aryloxy, acyloxy, amino, alkylamino, arylamino, acylamino, aralkylamino, nitro, acylthio, carboxamide, sulfonamide, sulfate, —OP(L)(OR 20 ) 2 , —X—C(L)-R 21 or —X—C(L)-X—R 21 ;
wherein R 1 may also be a sugar;
each X is independently O or NR wherein R is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl or aralkyl;
L is O or S;
R 2 and R 9 are independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, nitrile, aralkyl, alkoxyl, aryloxy, acyloxy, carboxyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;
R 5 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, alkylseleno, aralkylseleno, arylseleno, alkylthio, aralkylthio, arylthio, heteroaryl, or heteroaralkyl;
each R 3 , R 4 , R 6 , R 7 , R 13 and R 14 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;
or R 1 and R 2 taken together and/or R 8 and R 9 taken together, along with the carbon to which they are bonded, form —(C═O)—, —(C═S)—, —(C═N(OR 20 ))—, —(C═N(R 20 ))—, —(C═N(N(R 20 )(R 20 ))), or form an optionally substituted 3-8 membered ring containing up to two heteroatoms selected from N, O, and S; or
R 4 and R 5 taken together and/or R 5 and R 6 taken together form a double bond;
R 10 and R 11 taken together form a double bond;
R 12 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] q —R 21 , —[(W)—N(R 21 )C(O) q ]R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , —[(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;
wherein each W is independently a diradical, and q is 1, 2, 3, 4, 5, or 6;
each R 15 , R 16 , and R 17 are independently H, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino; or R 15 and R 16 taken together, along with the carbon to which they are bonded, form —C(O)— or —C(S)—;
each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4-8 membered optionally substituted ring;
each R 21 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0-6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4-8 membered optionally substituted ring which contains up to two heteroatoms selected from N, O, S, and P; and
each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )SO 2 (R 20 ), —COR 20 N(R 21 ) 2 , —OC(O)R 20 N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 21 ), —OS(O) 2 OR 20 , —S(O) 2 OR 20 , —OP(L)(OR 20 )(OR 20 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 );
with a cyclopropanating agent to form a second compound of formula 2, wherein:
R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 12 , R 13 , R 14 , R 15 , R 16 and R 17 in the second compound of formula 2 are as defined above; and R 10 and R 11 in the second compound of formula 2 taken together form a group represented by 1b
wherein Z is C(R 23 )(R 23 ); and each R 23 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, alkoxyl, aryloxy, acyloxy, silyloxy, nitrile, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , or —C(O)N(R 21 ) 2 ; and
b. reacting the second compound of formula 2 with a Lewis or Bronsted acid to form a compound of formula 1:
or a pharmaceutically acceptable salt thereof;
wherein each R 1 and R 8 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, alkoxyl, aryloxy, acyloxy, amino, alkylamino, arylamino, acylamino, aralkylamino, nitro, acylthio, carboxamide, sulfonamide, sulfate, —OP(L)(OR 20 ) 2 , —X—C(L)-R 21 or —X—C(L)-X—R 21 ;
wherein R 1 may also be a sugar;
each X is independently O or NR wherein R is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl or aralkyl;
L is O or S;
R 2 and R 9 are independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, nitrile, aralkyl, alkoxyl, aryloxy, acyloxy, carboxyl, halide, sulfhydryl, alkylthio, arylthio, aralkylthio, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;
R 5 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, alkylseleno, aralkylseleno, arylseleno, alkylthio, aralkylthio, arylthio, heteroaryl, or heteroaralkyl;
each R 3 , R 4 , R 6 , R 7 , R 13 and R 14 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino, heteroaryl, or heteroaralkyl;
or R 1 and R 2 taken together and/or R 8 and R 9 taken together, along with the carbon to which they are bonded, form —(C═O)—, —(C═S)—, —(C═N(OR 20 ))—, —(C═N(R 20 ))—, —(C═N(N(R 20 )(R 20 ))), or form an optionally substituted 3-8 membered ring containing up to two heteroatoms selected from N, O, and S; or
R 4 and R 5 taken together and/or R 5 and R 6 taken together form a double bond;
R 10 and R 11 taken together form a double bond;
R 12 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, hydroxyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, alkoxyl, —C(O)R 21 , —CO 2 R 21 , —SO 2 R 21 , —C(O)N(R 21 )(R 21 ), —[C(R 21 ) 2 ] q —R 21 , —[(W)—N(R 21 )C(o)] q R 21 , —[(W)—C(O)] q R 21 , —[(W)—C(O)O] q R 21 , —[(W)—OC(O)] q R 21 , —[(W)—SO 2 ] q R 21 , —[(W)—N(R 21 )SO 2 ] q R 21 , —[(W)—C(O)N(R 21 )] q R 21 , —[(W)—O] q R 21 , —[(W)—N(R 21 )] q R 21 , or —[(W)—S] q R 21 ;
wherein each W is independently a diradical, and q is 1, 2, 3, 4, 5, or 6;
R 15 , R 16 , and R 17 are independently H, alkoxyl, aryloxy, acyloxy, halide, hydroxyl, amino, alkylamino, arylamino, acylamino, aralkylamino; or R 15 and R 16 taken together, along with the carbon to which they are bonded, form —C(O)— or —C(S)—;
R 18 and R 19 are independently H, alkyl, aralkyl, halide, amido, or ester;
each R 20 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or any two occurrences of R 20 on the same substituent can be taken together to form a 4-8 membered optionally substituted ring;
each R 21 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl or —[C(R 20 ) 2 ] p —R 25 wherein p is 0-6; or any two occurrences of R 21 on the same substituent can be taken together to form a 4-8 membered optionally substituted ring which contains up to two heteroatoms selected from N, O, S, and P; and
each R 25 is independently H, hydroxyl, acylamino, —N(R 20 )COR 20 , —N(R 20 )C(O)OR 20 , —N(R 20 )SO 2 (R 20 ), —COR 20 N(R 20 ) 2 , —OC(O)R 20 )N(R 20 )(R 20 ), —SO 2 N(R 20 )(R 20 ), —N(R 20 )(R 20 ), —COOR 20 , —C(O)N(OH)(R 21 ), —OS(O) 2 OR 20 , —S(O) 2 OR 20 , —OP(L)(OR 20 )(OR 2 ), —NP(O)(OR 20 )(OR 20 ), or —P(O)(OR 20 )(OR 20 ).
2. The process according to claim 1 , wherein R 13 , R 14 , R 15 , R 16 , and R 17 are each hydrogen.
3. The process according to claim 1 , wherein R 1 is hydroxyl, sugar, —OP(L)(OR 20 ) 2 , —X—C(L)-R 21 , or —X—C(L)-X—R 21 , and R 2 is H; or R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.
4. The process according to claim 1 , wherein R 4 and R 5 taken together form a double bond.
5. The process according to claim 4 , wherein R 1 and R 2 taken together, along with the carbon to which they are bonded, form —C(O)—.
6. The process according to claim 3 , wherein R 1 is hydroxyl and R 2 is H.
7. The process according to claim 6 , wherein R 5 and R 6 taken together form a double bond.
8. The process according to claim 3 , wherein R 1 is —X—C(L)-X—R 21 .
9. The process according to claim 3 , wherein R 12 is —CO 2 R 21 and R 21 is aralkyl.
10. The process according to claim 1 , wherein R 8 and R 9 are each hydrogen, or R 8 and R 9 taken together, along with the carbon to which they are bonded, is —C(O)—.
11. The process according to claim 1 , wherein the cyclopropanating agent is a 1,1-haloalkylmetal complex.
12. The process according to claim 11 , wherein the 1,1-haloalkylmetal complex is formed from diiodomethane and Et 2 Zn, and the cyclopropanation is conducted in dichloromethane.
13. The process according to claim 1 , wherein the Lewis or Bronsted acid is selected from ZnI 2 , BF 3 , methanesulfonic acid, diaryloxyphosphoric acids, and HCl.
14. The process according to claim 1 , wherein for the compound of formula 2, the second compound of formula 2, and the compound of formula 1:
R 1 is protecting group —X—C(L)-X—R 21 , R 2 is H, R 5 and R 6 taken together form a double bond, and R 12 is protecting group —CO 2 -aralkyl,
further comprising removing the R 1 and R 12 protecting groups to form a second compound of formula 1 wherein R 1 is hydroxyl, R 2 is H, R 5 and R 6 taken together form a double bond, and R 12 is H.
15. The process according to claim 14 , wherein the second compound of formula 1 is oxidized using Al(Oi-Pr) 3 to form a third compound of formula 1, wherein R 1 and R 2 taken together, along with the carbon to which they are bonded, form —(C═O)—, R 4 and R 5 taken together form a double bond, and R 12 is H.